Mesa Laboratories CEO sells stock for $2.6 million

Published 24/03/2025, 18:42
Mesa Laboratories CEO sells stock for $2.6 million

Gary Owens, the President and CEO of Mesa Laboratories Inc. (NASDAQ:MLAB), a $687 million market cap company with strong revenue growth of 11.7%, reported a significant transaction involving the company’s common stock. According to InvestingPro analysis, the company currently trades above its Fair Value. On March 19, 2025, Owens sold 21,000 shares at an average price of $123.91 per share, totaling approximately $2.6 million. This sale was executed under a Rule 10b5-1 trading plan, which Owens adopted on September 12, 2024.

In addition to the sale, Owens also acquired 21,000 shares through the exercise of stock options at a price of $122.98 per share, amounting to a total value of approximately $2.58 million. Following these transactions, Owens holds 43,337 shares of Mesa Laboratories directly.

In other recent news, Mesa Laboratories reported a 13.2% increase in organic growth for the quarter, marking its strongest performance since 2022. The company exceeded expectations for both revenue and earnings, showcasing robust financial health. Analysts at KeyBanc Capital Markets have maintained a Sector Weight rating for Mesa Labs, noting the company’s strategic positioning for future consolidation. Mesa Labs is preparing its balance sheet for potential acquisitions, with $30 million in purchasing capacity and favorable EV/EBITDA ratios, indicating readiness to accelerate its consolidation strategy.

Additionally, Mesa Laboratories announced a regular quarterly dividend of $0.16 per share, scheduled for payment on March 17, 2025, to shareholders on record as of February 28, 2025. This move underscores the company’s commitment to returning value to its shareholders. The company has also issued forward-looking statements predicting future revenues and growth while acknowledging potential risks and uncertainties. Investors are encouraged to review Mesa Labs’ official financial documents for a more comprehensive understanding of these projections and associated risks.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.